Skip to main content

Table 4 MICA-LDA performance on six mass spectral data sets

From: A high performance profile-biomarker diagnosis for mass spectral profiles

Cross validation Ave. classification rate ± std (%) Ave. sensitivity ± std (%) Ave. specificity ± std (%)
50%HOCV    
Colorectal 96.21±02.07 96.20±03.70 96.29±02.53
HCC 98.19±01.67 100.0±00.00 96.50±03.21
Ovarian-qaqc 90.62±02.73 91.93±04.67 89.58±04.05
Prostate 93.03±03.05 96.15±03.24 89.42±05.24
Cirrhotic 98.93±01.37 97.52±03.05 99.97±00.28
Three-class 96.84±01.32 98.69±01.49 96.21±02.10
10-fold CV    
Colorectal 96.26 ± 06.77 95.00 ± 15.81 96.90 ± 06.55
HCC 97.38 ± 03.39 100.0 ± 00.00 95.00 ± 06.45
Ovarian-qaqc 88.46 ± 07.16 91.78 ± 13.41 86.03 ± 06.54
Prostate 90.87 ± 07.86 92.86 ± 10.10 88.57 ± 13.65
Cirrhotic 99.17 ± 02.64 98.00 ± 06.32 100.0 ± 00.00
Three-class 97.33 ± 03.44 96.25 ± 06.04 98.57 ± 04.52